Screen Printing Inks Printing and Marking Inks Colorant Chromatics™ Inks

Screen Printing Inks Printing and Marking Inks Colorant Chromatics™ Inks

Screen Printing Inks Printing and Marking Inks Colorant Chromatics™ Inks

Screen Printing Inks Printing and Marking Inks Colorant Chromatics™ Inks

Screen Printing Inks Printing and Marking Inks Colorant Chromatics™ Inks

These unique MEVOPUR™ concentrates use pre-tested ingredients and prescribed manufacturing practices to help customers achieve compliance with pharmaceutical packaging regulations through 2025 and beyond.  They are formulated without animal-derived substances and phthalates, and have been pre-tested for compliance with: •    ISO 10993-1 and USP parts , (including class VI) •    European Pharmacopoeia, monograph 3.1.15 •    USP and •    elemental analysis, as per ICH Q3D In this case, the newest amber masterbatches comply not only with the current USP 661 standard, which governs plastic materials used in pharmaceutical packaging, but they have also been tested for compliance to USP regulations that won’t become effective until December 2025.

Compliance: Formulated without intentionally added fluoropolymers, fluoroelastomers, or other per- and polyfluoroalkyl substances, Evoluscend™ additive offers a non-PFAS alternative to traditional products, supporting manufacturers sustainability goals and regulatory compliance initiatives With the launch of Colorant Chromatics™ Evoluscend™ non-PFAS mold release additive for high-temperature polymers, we are proud to offer a product that not only can meet the high standards of modern manufacturing but also can support the sustainability goals and regulatory compliance needs of our clients by offering an alternative to intentionally added PFAS materials," said Deborah Sondag, Global Marketing Manager, Colorant Chromatics at Avient.

The company noted the following segment highlights: The Color, Additives and Inks segment delivered record operating income of $89 million during the first quarter, a 40% increase over the prior year. Three Months Ended March 31, 2021 2020 Sales: Color, Additives and Inks $ 609.3 $ 256.5 Specialty Engineered Materials 216.5 185.3 Distribution 362.7 289.5 Corporate and eliminations (26.2) (19.8) Sales $ 1,162.3 $ 711.5 Gross margin: Color, Additives and Inks $ 197.5 $ 89.4 Specialty Engineered Materials 64.7 52.6 Distribution 39.3 33.6 Corporate and eliminations 0.9 (4.1) Gross margin $ 302.4 $ 171.5 Selling and administrative expense: Color, Additives and Inks $ 108.7 $ 48.9 Specialty Engineered Materials 30.5 30.3 Distribution 15.3 14.2 Corporate and eliminations 27.5 25.3 Selling and administrative expense $ 182.0 $ 118.7 Operating income: Color, Additives and Inks $ 88.8 $ 40.5 Specialty Engineered Materials 34.2 22.3 Distribution 24.0 19.4 Corporate and eliminations (26.6) (29.4) Operating income $ 120.4 $ 52.8 Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA): Color, Additives and Inks $ 116.2 $ 51.4 Specialty Engineered Materials 42.0 29.8 Distribution 24.2 19.5 Corporate and eliminations (24.9) (28.0) Other income, net 1.5 1.6 EBITDA $ 159.0 $ 74.3 12 Attachment 7 Avient Corporation Reconciliation of Non-GAAP Financial Measures (Unaudited) (In millions, except per share data) Senior management uses gross margin before special items and operating income before special items to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and how it may serve as a basis for future performance. Reconciliation of Pro Forma Adjusted Earnings per Share: Three Months Ended March 31, 2020 Net income from continuing operations attributable to Avient shareholders $ 33.1 Special items, after tax (Attachment 3) 8.6 Adjusted net income from continuing operations excluding special items 41.7 Clariant MB pro forma adjustments to net income from continuing operations(2) 7.8 Pro forma adjusted net income from continuing operations attributable to Avient shareholders $ 49.5 Weighted average diluted shares 86.7 Pro forma impact to diluted shares from January 2020 equity offering 6.1 Pro forma weighted average diluted shares 92.8 Adjusted EPS - excluding special items pro forma for Clariant MB acquisition $ 0.53 Year Ended December 31, 2020 Reconciliation of Pro Forma Adjusted Earnings per Share: Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(2) Pro Forma Adjusted Avient Sales $ 3,242.1 $ — $ 3,242.1 $ 540.4 $ 3,782.5 Operating income $ 189.3 $ 73.7 $ 263.0 $ 45.0 $ 308.0 Interest expense, net (74.6) 10.1 (64.5) (18.1) (82.6) Other income, net 24.3 (17.6) 6.7 — 6.7 Income taxes (5.2) (41.4) (46.6) (6.2) (52.8) Net income attributable to noncontrolling interests (1.8) — (1.8) — (1.8) Net income from continuing operations attributable to Avient shareholders $ 132.0 $ 24.8 $ 156.8 $ 20.7 $ 177.5 Weighted average diluted shares 90.6 Impact to diluted shares from January 2020 equity offering 1.5 Pro forma weighted average diluted shares 92.1 Pro forma adjusted EPS $ 1.93 (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition 14 Year Ended December 31, 2019 Reconciliation of Pro Forma Adjusted Earnings per Share: Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(3) Pro Forma Adjusted Avient Sales $ 2,862.7 $ — $ 2,862.7 $ 1,118.6 $ 3,981.3 Operating income $ 156.8 $ 71.7 $ 228.5 $ 72.9 $ 301.4 Interest expense, net (59.5) — (59.5) (33.4) (92.9) Other income, net 12.1 (10.0) 2.1 — 2.1 Income taxes (33.7) (5.9) (39.6) (9.1) (48.7) Net income attributable to noncontrolling interests (0.2) — (0.2) — (0.2) Net income from continuing operations attributable to Avient shareholders $ 75.5 $ 55.8 $ 131.3 $ 30.4 $ 161.7 Weighted average diluted shares 77.7 Impact to diluted shares from January 2020 equity offering 15.3 Pro forma weighted average diluted shares 93.0 Pro forma adjusted EPS $ 1.74 (3) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition 15 Reconciliation of EBITDA by Segment Three Months Ended March 31, Year Ended December 31, 2021 2020 2020 2019 2018 Operating income: Color, Additives and Inks $ 88.8 $ 40.5 $ 180.8 $ 147.4 $ 158.5 Specialty Engineered Materials 34.2 22.3 94.4 83.7 72.3 Distribution 24.0 19.4 69.5 75.4 71.5 Corporate and eliminations (26.6) (29.4) (155.4) (149.7) (123.7) Operating income $ 120.4 $ 52.8 $ 189.3 $ 156.8 $ 178.6 Items Below OI in Corporate Other income, net $ 1.5 $ 1.6 $ 24.3 $ 12.1 $ (12.9) Depreciation & Amortization: Color, Additives and Inks $ 27.4 $ 10.9 $ 75.1 $ 42.7 $ 44.3 Specialty Engineered Materials 7.8 7.5 30.0 29.5 23.2 Distribution 0.2 0.1 0.7 0.5 0.7 Corporate and eliminations 1.7 1.4 9.2 5.4 4.4 Depreciation & Amortization $ 37.1 $ 19.9 $ 115.0 $ 78.1 $ 72.6 EBITDA Color, Additives and Inks $ 116.2 $ 51.4 $ 255.9 $ 190.1 $ 202.8 Specialty Engineered Materials 42.0 29.8 124.4 113.2 95.5 Distribution 24.2 19.5 70.2 75.9 72.2 Corporate and eliminations (24.9) (28.0) (146.2) (144.3) (119.3) EBITDA $ 159.0 $ 74.3 $ 328.6 $ 247.0 $ 238.3 EBITDA as a % of Sales: Color, Additives and Inks 19.1 % 20.0 % 17.0 % 18.9 % 19.4 % Specialty Engineered Materials 19.4 % 16.1 % 17.6 % 15.2 % 14.8 % Distribution 6.7 % 6.7 % 6.3 % 6.4 % 5.7 % 16 Reconciliation of Pro Forma EBITDA - Color, Additives and Inks Three Months Ended March 31, Year Ended December 31, 2020 2020 2019 2018 Sales: Color, Additives and Inks $ 256.5 $ 1,502.9 $ 1,003.8 $ 1,046.5 Clariant MB pro forma adjustments(4) 279.4 540.4 1,118.6 1,209.8 Pro forma sales $ 535.9 $ 2,043.3 $ 2,122.4 $ 2,256.3 Operating income: Color, Additives and Inks $ 40.5 $ 180.8 $ 147.4 $ 158.5 Clariant MB pro forma adjustments(4) 23.0 45.0 72.9 80.3 Pro forma operating income $ 63.5 $ 225.8 $ 220.3 $ 238.8 Depreciation & amortization: Color, Additives and Inks $ 10.9 $ 75.1 $ 42.7 $ 44.3 Clariant MB pro forma adjustments(4) 15.1 30.1 60.3 61.2 Pro forma depreciation & amortization $ 26.0 $ 105.2 $ 103.0 $ 105.5 Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA): Color, Additives and Inks $ 51.4 $ 255.9 $ 190.1 $ 202.8 Clariant MB pro forma adjustments(4) 38.1 75.1 133.2 141.5 Pro forma EBITDA $ 89.5 $ 331.0 $ 323.3 $ 344.3 Pro forma EBITDA as a % of Sales 16.7 % 16.2 % 15.2 % 15.3 % Three Months Ended March 31, Year Ended December 31, Reconciliation to Adjusted EBITDA: 2021 2020 2020 2019 2018 Net income from continuing operations – GAAP $ 79.7 $ 33.1 $ 133.8 $ 75.7 $ 87.4 Income tax expense 22.9 11.9 5.2 33.7 14.4 Interest expense 19.3 9.4 74.6 59.5 62.8 Debt extinguishment cost — — 1.1 Depreciation and amortization from continuing operations 37.1 19.9 115.0 78.1 72.6 EBITDA $ 159.0 $ 74.3 $ 328.6 $ 247.0 $ 238.3 Special items, before tax 2.4 9.6 66.2 61.7 59.5 Interest expense included in special items — — (10.1) — — Accelerated depreciation included in special items (0.5) — (3.2) — (3.0) Adjusted EBITDA $ 160.9 $ 83.9 $ 381.6 $ 308.7 $ 294.8 Reconciliation of Pro Forma Sales: Three Months Ended March 31, 2020 Sales $ 711.5 Clariant MB pro forma adjustment to sales(4) 279.4 Pro forma sales $ 990.9 (4) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) 17 Avient Announces Record First Quarter 2021 Results; Increases Full Year Guidance.pdf NEWS RELEASE 4.29 232pm News Release (002).pdf

Cesa™ Non-PFAS Process Aid for Extrusion: for use in polyethylene (PE) and polypropylene (PP) applications, it reduces friction between the polymer and the metal during extrusion comparable to a traditional processing aid but is formulated without fluoropolymers which may be classifiable as per- and polyfluorinated substances (PFAS) and will be presented during Avient’s technical seminar at NPE, “PFAS Alternatives: 2024 and Beyond,” by Sean Bernhardt, Senior Research and Development Manager, Color, Additives, & Inks, Americas at Avient, on May 7 at 3 p.m. and May 8 at 1 p.m. ColorMatrix™ AAnchor™ Acetaldehyde Control Technology: a finalist for Product Technology Innovation of the Year for sustainable packaging at the Plastics Recycling Show Europe (PRSE) 2024, this specially formulated acetaldehyde scavenger for PET packaging developed to improve recyclability, enhance bottle quality, and meet compliance with regulatory limits – winner will be announced during PRSE 2024 in Amsterdam, June 19-20, 2024

Inks, dyes and integrated polymer-based solutions are examples. Inks and Dyes For instance a label may contain both a 3D bar code, a hologram and a covert ink or polymer-based solution.